Cardinal Health, Inc. (CAH) is owned by a number of high-value investors. Its largest direct holder is Michael C. Kaufmann Director, Chief Executive Officer and Interim Chief Financial Officer with 419,536 shares. The second-largest direct holder is Victor L. Crawford Chief Executive Officer, Pharmaceutical segment, with 52,218 shares of the company’s stock. In third place with 48,925 shares of CAH is Jessica L Mayer Chief Legal and Compliance Officer.
Now turning to institutional ownership of Cardinal Health, Inc. (CAH), The Vanguard Group, Inc. is the top holder with 35.39 million shares. The next largest fund holder of this company’s stock is SSgA Funds Management, Inc. with 21.13 million shares. In the third-place spot with 15.13 million shares is BlackRock Fund Advisors.
This company’s stock price was $48.88 at the previous market close, with its latest volume reaching 2,987,411. Compare that to its average daily volume of 2.82M. Given the fact that this stock has 297.00M shares outstanding, its current market value is sitting at $14.52B. This publicly-traded stock’s 60-month Beta is 1.32. Its Price to Sales ratio is 0.10, its Price to Cash Flow ratio is 5.74, and its Price to Book ratio is 2.29.
CAH stock has achieved a 5-day range of $44.30 to $48.92, with a total performance of +10.21% during that period. Meanwhile, in the past month of trading, this stock has traded in the range of $41.25 to $48.92, generating a +10.21% change during the period. In the past three months, this stock’s price has changed by +9.50%, trading in the range of $41.03 to $49.97.
In the past 5 days, shares of CAH have made a new high 5 times. In the last month, it has made a new high 6 times, and in the past 3 months, it has made a new high 11 times.
Now let’s turn to this public company’s earnings. For the quarter ending 6/29/2019, the earnings per share (EPS) was reported at 1.11. This is a 0.18 difference compared to the consensus estimate of 0.93, amounting to an earnings surprise of 19.40%. In the previous quarter, which ended in 6/29/2019, the consensus estimate was 1.43, making for an earnings surprise of 11.20%. For the quarter ending 12/30/2018, EPS was reported at 1.29, generating a 18.30% earnings surprise.
The Net Income for the most recent full fiscal year, which ended in 06-2019, was $1.36 billion. This is compared to the prior year, where Net Income was $256.0 million. Meanwhile, this company’s Operating Cash Flow was $2.72 billion for the year, compared to $2.77 billion in 2017. Capital Expenditures for the year were reportedly -$328.0 million, compared to -$384.0 million, and Free Cash flow was $2.39 billion compared to the prior year’s $2.38 billion.
Cardinal Health, Inc. (CAH) stock currently has a Financial Strength score of 6/10. This is due to a combination of factors, including a Cash to Debt ratio of 0.32, an Equity to Asset ratio of 0.15, a Debt to Equity ratio of 1.27 and a Debt to EBITDA of 2.94. The Interest Coverage of this stock is 5.88, its Piotroski F-Score is 7, its Altman Z-Score is 4.2 and its Beneish M-Score is -2.53.
This publicly-traded company’s Profitability and Growth score is 7/10, thanks to a combination of things: an Operating Margin of 1.19, a Net Margin of 0.94, a ROE of 22.29, and a ROC of 63.03.
Shifting focus now to Valuation and Return for CAH, this company’s Price to Median PS Value is 0.67. Price to Peter Lynch Fair Value for CAH is now 1.98. Meanwhile, its Forward Rate of Return (Yactman) is 19.02.
Certain ratios provide helpful insights into how a stock is performing. The Quick Ratio for CAH is sitting at 0.54, while its Current Ratio is 1.07 and its PEG Ratio is 1.93. This stock’s PB Ratio is 2.31, its PS Ratio is 0.1, its Forward PE Ratio is 9.62, and its PE Ratio without NRI is 10.83. Similarly, its Shiller PE Ratio is 15.47, its Price to Owner Earnings is 5.18, its Price to Free Cash Flow is 6.11 and its Price to Operating Cash Flow is 5.39.